BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6132413)

  • 1. Rebound insomnia and rebound anxiety: a review.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine hypnotics and insomnia.
    Kales A
    Hosp Pract (Off Ed); 1990 Sep; 25 Suppl 3():7-21; discussion 22-3. PubMed ID: 1976124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM].
    Clarenbach P; Steinberg R; Weess HG; Berger M
    Nervenarzt; 1995 Oct; 66(10):723-9. PubMed ID: 7501087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound phenomena: results of a 10 years' (1970--1980) literature review.
    Lupolover R; Dazzi H; Ward J
    Int Pharmacopsychiatry; 1982; 17(4):194-237. PubMed ID: 6136487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications.
    Lader M; Lawson C
    Clin Neuropharmacol; 1987 Aug; 10(4):291-312. PubMed ID: 2902919
    [No Abstract]   [Full Text] [Related]  

  • 10. Rebound insomnia: its determinants and significance.
    Roehrs T; Vogel G; Roth T
    Am J Med; 1990 Mar; 88(3A):39S-42S. PubMed ID: 1968719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine withdrawal and rebound insomnia.
    Morgan K; Tomeny M
    Acta Psychiatr Scand; 1989 Sep; 80(3):297-8. PubMed ID: 2573235
    [No Abstract]   [Full Text] [Related]  

  • 13. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    Kales A; Scharf MB; Kales JD; Soldatos CR
    JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound insomnia: a new clinical syndrome.
    Kales A; Scharf MB; Kales JD
    Science; 1978 Sep; 201(4360):1039-41. PubMed ID: 684426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early morning insomnia with rapidly eliminated benzodiazepines.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Science; 1983 Apr; 220(4592):95-7. PubMed ID: 6131538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytics and sedative/hypnotics dependence.
    Busto UE; Sellers EM
    Br J Addict; 1991 Dec; 86(12):1647-52. PubMed ID: 1686199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety or depression during withdrawal of hypnotic treatments.
    Lader M
    J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.